The Future of Drug-Pricing Transparency.
作者信息
Feldman William B, Rome Benjamin N, Avorn Jerry, Kesselheim Aaron S
机构信息
From the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics (W.B.F., B.N.R., J.A., A.S.K.) and the Division of Pulmonary and Critical Care Medicine (W.B.F.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (W.B.F., B.N.R., J.A., A.S.K.) - both in Boston.
出版信息
N Engl J Med. 2021 Feb 11;384(6):489-491. doi: 10.1056/NEJMp2033734. Epub 2021 Jan 13.
PMID:33440087
Abstract
摘要
相似文献
1
The Future of Drug-Pricing Transparency.药品定价透明度的未来。
N Engl J Med. 2021 Feb 11;384(6):489-491. doi: 10.1056/NEJMp2033734. Epub 2021 Jan 13.
2
Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.在广告中披露处方药价格——法律与公共卫生问题
N Engl J Med. 2018 Dec 13;379(24):2290-2293. doi: 10.1056/NEJMp1814065. Epub 2018 Nov 14.
3
The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.联邦制的负担：各州控制处方药成本尝试面临的挑战。
J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.
4
Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.《药剂福利管理人员控制处方药成本不断上涨的政策建议：美国医师学会立场文件》。
Ann Intern Med. 2019 Dec 3;171(11):823-824. doi: 10.7326/M19-0035. Epub 2019 Nov 12.
5
Value-Based Pricing and State Reform of Prescription Drug Costs.基于价值的定价与处方药成本的国家改革。
JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.
6
Pharmaceuticals and medical devices: Medicare Part D. Issue brief.药品和医疗器械：医疗保险D部分。问题简报。
Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32.
7
Value-Based Pricing and Patient Access for Specialty Drugs.专科药物的价值定价与患者可及性
JAMA. 2018 Jun 5;319(21):2169-2170. doi: 10.1001/jama.2018.5367.
8
State Remedies For Costly Prescription Drugs.针对昂贵处方药的国家补救措施。
NCSL Legisbrief. 2018 Aug;26(29):1-2.
9
Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.谁能从药品折扣中受益？制药商与医院就贫困护理项目展开争斗。
Mod Healthc. 2013 Jul 15;43(28):8-9.
10
Value-Based Pricing for Drugs: Theme and Variations.基于价值的药品定价：主题与变奏
JAMA. 2018 Jun 5;319(21):2165-2166. doi: 10.1001/jama.2018.4871.
引用本文的文献
1
Challenges Related to Out-of-Pocket Costs in Heart Failure Management.心力衰竭管理中与自付费用相关的挑战
Circ Heart Fail. 2025 Mar;18(3):e011584. doi: 10.1161/CIRCHEARTFAILURE.124.011584. Epub 2025 Feb 28.
2
Getting Cost Discussions Right: Nudging Patients to Avoid Cognitive Pitfalls.正确进行费用讨论：引导患者避免认知陷阱。
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009447. doi: 10.1161/CIRCOUTCOMES.122.009447. Epub 2022 Dec 6.
3
Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial.实时处方效益推荐对患者自付费用的影响：一项集群随机临床试验。
JAMA Intern Med. 2022 Nov 1;182(11):1129-1137. doi: 10.1001/jamainternmed.2022.3946.
4
National trends in prescription drug expenditures and projections for 2021.全国处方药支出趋势及 2021 年预测。
Am J Health Syst Pharm. 2021 Jul 9;78(14):1294-1308. doi: 10.1093/ajhp/zxab160.
Zotero 插件